The PI3K/Akt pathway is frequently dysregulated in colorectal cancer (CRC), and CRC patients commonly demonstrate mutations in the PIK3CA gene, encoding the catalytic subunit of PI3K [12]. This evidence concerns the gene PIK3CA and colorectal cancer.